0.10Open0.10Pre Close0 Volume15 Open Interest2.50Strike Price0.00Turnover346.57%IV58.54%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier7DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.2621Delta0.4139Gamma16.40Leverage Ratio-0.0185Theta0.0001Rho4.30Eff Leverage0.0007Vega
BeyondSpring Stock Discussion
BeyondSpring Presents Updated Efficacy Results from a Phase 2 IIT Study of Triple IO Combo of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on Prior Immune Checkpoint Inhibitors at the 39th SITC Annual Meeting
BeyondSpring (NASDAQ: BYSI)presented updated Phase 2 trial results for a triple combination therapy in non-small cell lung cancer (NSCLC) patients who progressed after PD-1/PD-L1 inhibitor treatment. The study of 30 patients, with...
A quick recap for the weekend ending March 24, 2024.
Eight stocks with >30% YTD
$Latham Group (SWIM.US)$38.40%
$DoubleDown Interactive (DDI.US)$67.63%
$Hippo Holdings (HIPO.US)$88.93%
$Vaxart (VXRT.US)$119.97%
$Ocugen (OCGN.US)$185.22%
$BeyondSpring (BYSI.US)$246.67%
$Vincerx Pharma (VINC.US)$325.42%
$Airship AI (AISP.US)$452.94%
Top 5 Gainers (22 Mar 2024)
$Murano Global Investments (MRNO.US)$120.89% ...
$Aterian (ATER.US)$ loading zone 1.1-1.2 looking for 1.8-2.6 PT
$Innovative Eyewear (LUCY.US)$ loading zone 1.2-1.45 looking for 2.4-3.8 PT
$WiSA Technologies (WISA.US)$ loading zone 0.13-0.14 no actual PT could be squeeze
$BeyondSpring (BYSI.US)$ loading zone 2.12-2.28 looking fo...
$Aterian (ATER.US)$ 1.16 entry
No comment yet